PortIO

Port-IO is a medical device company developing an implantable intraosseous (IO) access device designed for long-term use in patients with difficult venous access (DVA). The company's technology provides a reliable alternative to traditional central venous catheters and peripheral IVs by utilizing the bone marrow space for the delivery of fluids and medications, including chemotherapy and blood products. Port-IO aims to reduce the complications associated with long-term vascular access, such as infections and thrombosis, while improving the quality of life for patients requiring frequent infusions. The system is designed to be easily accessible for healthcare providers while maintaining a low profile for patient comfort.